Home > Journals > Minerva Urology and Nephrology > Past Issues > Minerva Urology and Nephrology 2021 August;73(4) > Minerva Urology and Nephrology 2021 August;73(4):421-3

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

MINERVA OPINION EDITORIAL   

Minerva Urology and Nephrology 2021 August;73(4):421-3

DOI: 10.23736/S2724-6051.21.04525-0

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Senescence in prostate cancer: is there sufficient evidence to move forward?

Valerie CARPENTER 1, 2 , Riccardo AUTORINO 3, David A. GEWIRTZ 1, 2

1 School of Medicine, Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA; 2 Massey Cancer Center, Richmond, VA, USA; 3 Division of Urology, Department of Surgery, VCU Health, Richmond, VA, USA



top of page